Atara Biotherapeutics logo

Atara Biotherapeutics Share Price (NASDAQ: ATRA)

$12.53

0.19

(1.54%)

Live

Last updated on

Check the interactive Atara Biotherapeutics Stock chart to analyse performance

Atara Biotherapeutics stock performance

as on August 26, 2025 at 12:38 AM IST

  • Today's Low:$12.50
    Today's High:$12.53

    Day's Volatility :0.24%

  • 52 Weeks Low:$5.01
    52 Weeks High:$18.71

    52 Weeks Volatility :73.24%

Atara Biotherapeutics Stock Returns

PeriodAtara Biotherapeutics IncSector (Health Care)Index (Russel 2000)
3 Months
64.75%
6.0%
0.0%
6 Months
70.21%
-7.2%
0.0%
1 Year
75.53%
-11.1%
0.0%
3 Years
-87.75%
5.5%
-10.0%

Atara Biotherapeutics Inc Key Stats

Check Atara Biotherapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$12.34
Open
$11.91
Today's High
$12.5
Today's Low
$12.03
Market Capitalization
$86.7M
Today's Volume
$90.7K
52 Week High
$18.705
52 Week Low
$5.005
Revenue TTM
$188.7M
EBITDA
$24.0M
Earnings Per Share (EPS)
$0.72
PE Ratio
17.14
Profit Margin
3.07%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-2014.86%

Stock Returns calculator for Atara Biotherapeutics Stock including INR - Dollar returns

The Atara Biotherapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Atara Biotherapeutics investment value today

Current value as on today

₹1,82,571

Returns

₹82,571

(+82.57%)

Returns from Atara Biotherapeutics Stock

₹78,236 (+78.24%)

Dollar Returns*

₹4,335 (+4.33%)

Indian investors sentiment towards Atara Biotherapeutics Stock

38%

Period: Jul 25, 2025 to Aug 24, 2025. Change in 30 Days versus previous period

Search interest for Atara Biotherapeutics Stock from India on INDmoney has increased by 38% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Atara Biotherapeutics Inc

  • Name

    Holdings %

  • EcoR1 Capital, LLC

    8.21%

  • Redmile Group, LLC

    6.33%

  • Vanguard Group Inc

    2.73%

  • Bank of America Corp

    2.68%

  • Acadian Asset Management LLC

    1.65%

  • Vestal Point Capital LP

    1.35%

Analyst Recommendation on Atara Biotherapeutics Stock

Rating
Trend

Buy

    61%Buy

    30%Hold

    7%Sell

Based on 13 Wall street analysts offering stock ratings for Atara Biotherapeutics(by analysts ranked 0 to 5 stars)

Atara Biotherapeutics Share Price Target

What analysts predicted

Upside of 30.35%

Target:

$16.33

Current:

$12.53

Atara Biotherapeutics share price target is $16.33, a slight Upside of 30.35% compared to current price of $12.53 as per analysts' prediction.

Atara Biotherapeutics Stock Insights

  • Price Movement

    In the last 7 days, ATRA stock has moved up by 7.5%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 98.14M → 17.57M (in $), with an average decrease of 82.1% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, 38.01M → 2.38M (in $), with an average decrease of 93.7% per quarter
  • ATRA vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.4% return, outperforming this stock by 201.6%

Atara Biotherapeutics Technicals Summary

Sell

Neutral

Buy

Atara Biotherapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Atara Biotherapeutics Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Atara Biotherapeutics Inc logo
4.49%
70.21%
75.53%
-87.75%
-96.27%
Regeneron Pharmaceuticals, Inc. logo
5.52%
-17.35%
-50.85%
-1.12%
-3.68%
Beone Medicines Ltd logo
6.51%
21.35%
57.45%
73.21%
25.84%
Vertex Pharmaceuticals Incorporated logo
-14.26%
-17.97%
-18.13%
40.27%
45.64%
Alnylam Pharmaceuticals, Inc. logo
39.9%
82.53%
68.83%
115.41%
241.51%

About Atara Biotherapeutics Inc

Atara Biotherapeutics, Inc. engages in the development of transformative therapies for patients with cancer and autoimmune disease in the United States and the United Kingdom. Its lead product includes Tab-cel (tabelecleucel), a T-cell immunotherapy program that is in Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) with post-transplant lymphoproliferative disease, as well as other EBV-driven diseases. The company has research collaboration agreements with Memorial Sloan Kettering Cancer Center, and Council of the Queensland Institute of Medical Research. Atara Biotherapeutics, Inc. was incorporated in 2012 and is headquartered in Thousand Oaks, California.
Organization
Atara Biotherapeutics
Employees
38
CEO
Dr. Anhco Nguyen Ph.D.
Industry
Health Technology

Key Management of Atara Biotherapeutics Inc

NameTitle
Dr. Anhco Nguyen Ph.D.
President, CEO & Director
Ms. Yanina Grant-Huerta
Chief Accounting Officer & Principal Accounting Officer
Alex Chapman
Vice President of Corporate Communications & Investor Relations
Mr. John Chao
Head of Legal
Mr. Jim Sesic
Senior Vice President of Regulatory Affairs

Important FAQs about investing in ATRA Stock from India :

What is Atara Biotherapeutics share price today?

Atara Biotherapeutics share price today is $12.53 as on . Atara Biotherapeutics share today touched a day high of $12.53 and a low of $12.50.

What is the 52 week high and 52 week low for Atara Biotherapeutics share?

Atara Biotherapeutics share touched a 52 week high of $18.71 and a 52 week low of $5.01. Atara Biotherapeutics stock price today i.e. is trending at $12.53, lower by 33.01% versus the 52 week high.

How to invest in Atara Biotherapeutics Stock (ATRA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Atara Biotherapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Atara Biotherapeutics Shares that will get you 0.1197 shares as per Atara Biotherapeutics share price of $12.53 per share as on August 26, 2025 at 12:38 AM IST.

What is the minimum amount required to buy Atara Biotherapeutics Stock (ATRA) from India?

Indian investors can start investing in Atara Biotherapeutics (ATRA) shares with as little as ₹87.537 or $1 (as of August 25, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹875.37 in Atara Biotherapeutics stock (as per the Rupee-Dollar exchange rate as on August 25, 2025). Based on Atara Biotherapeutics share’s latest price of $12.53 as on August 26, 2025 at 12:38 AM IST, you will get 0.7981 shares of Atara Biotherapeutics. Learn more about fractional shares .

What are the returns that Atara Biotherapeutics has given to Indian investors in the last 5 years?

Atara Biotherapeutics stock has given -96.27% share price returns and 18.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?